According to a study published in Frontiers in Psychiatry on 18 November 2026, people with bipolar disorder who have been hospitalised for acute manic episodes report mixed emotions about their care, actively try to manage their own behaviour to avoid restraint, and strongly prefer medication-based (chemical) restraint over physical restraint, which they associate with confinement and distress.
The research, led by Patitta Chanhom and colleagues from the Department of Psychiatry at Prince of Songkla University in Thailand, involved semi-structured interviews with ten outpatients who had been admitted to Songklanagarind Hospital for a manic episode within the previous three months to a year. Participants were interviewed between June 2023 and March 2024, after their condition had stabilised.
Using reflexive thematic analysis, the researchers identified five main themes in the interviews: mixed emotions toward hospital experiences; active efforts to manage behaviour during admission; perceptions of stigma and discrimination in care; preferences for medical over physical restraints; and fostering dignity and autonomy through informed consent.
Participants described ambivalent feelings about being hospitalised. While some valued positive relationships with healthcare providers that fostered understanding and empathy, others reported feeling stigmatised or treated unfairly. The study noted that previous experiences with restraint influenced how participants behaved during later admissions — many said they tried to self-regulate their actions to avoid being physically restrained again.
Physical restraint, which in Thailand typically involves soft devices such as wrist or ankle restraints, waist belts, and chest vests, was viewed more negatively than chemical restraint. Participants described physical restraint as distressing and dehumanising. Chemical restraint — the use of medication to calm a patient — was seen as less intrusive and more acceptable, especially when combined with compassionate care and clear communication from staff.
According to the study, participants emphasised the importance of equitable, stigma-free treatment. They wanted better communication from healthcare providers, informed consent before interventions, consistent support, and respectful treatment that would foster a sense of safety, belonging, and empowerment.
The researchers noted that their findings align with a broader shift in mental healthcare toward recovery-oriented, patient-centred models that prioritise patient autonomy and shared decision-making. However, they acknowledged limitations: the study was conducted at a single hospital in Thailand, relied on retrospective recall of acute episodes, and involved a small sample of ten participants, all of whom had stable clinical conditions at the time of interview. The researchers also noted that their own professional backgrounds as psychiatrists and their affiliation with the study hospital could have influenced participants' willingness to speak openly.
Despite these limitations, the authors argue that the findings offer valuable insights for improving inpatient care during manic episodes. They recommend that healthcare providers focus on reducing stigma, building positive therapeutic relationships, and supporting patients' autonomy and dignity to promote recovery and more humane treatment experiences.